Literature DB >> 15450160

Translational regulatory mechanisms in persistent forms of synaptic plasticity.

Raymond J Kelleher1, Arvind Govindarajan, Susumu Tonegawa.   

Abstract

Memory and synaptic plasticity exhibit distinct temporal phases, with long-lasting forms distinguished by their dependence on macromolecular synthesis. Prevailing models for the molecular mechanisms underlying long-lasting synaptic plasticity have largely focused on transcriptional regulation. However, a growing body of evidence now supports a crucial role for neuronal activity-dependent mRNA translation, which may occur in dendrites for a subset of neuronal mRNAs. Recent work has begun to define the signaling mechanisms coupling synaptic activation to the protein synthesis machinery. The ERK and mTOR signaling pathways have been shown to regulate the activity of the general translational machinery, while the translation of particular classes of mRNAs is additionally controlled by gene-specific mechanisms. Rapid enhancement of the synthesis of a diverse array of neuronal proteins through such mechanisms provides the components necessary for persistent forms of LTP and LTD. These findings have important implications for the synapse specificity and associativity of protein synthesis-dependent changes in synaptic strength.

Entities:  

Mesh:

Year:  2004        PMID: 15450160     DOI: 10.1016/j.neuron.2004.09.013

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  235 in total

1.  Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization.

Authors:  Hansen Wang; Susan S Kim; Min Zhuo
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Mammalian target of rapamycin in spinal cord neurons mediates hypersensitivity induced by peripheral inflammation.

Authors:  E Norsted Gregory; S Codeluppi; J A Gregory; J Steinauer; C I Svensson
Journal:  Neuroscience       Date:  2010-06-09       Impact factor: 3.590

3.  Fear and safety learning differentially affect synapse size and dendritic translation in the lateral amygdala.

Authors:  Linnaea E Ostroff; Christopher K Cain; Joseph Bedont; Marie H Monfils; Joseph E Ledoux
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

4.  Fragile X mental retardation protein: regulator of specific mRNAs or master regulator of global translation?

Authors:  Denise Cook; Scott A Cameron; Emma V Jones
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 5.  mRNA translation: regulating an out of soma experience.

Authors:  David G Wells
Journal:  Curr Opin Cell Biol       Date:  2012-07-06       Impact factor: 8.382

6.  Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment.

Authors:  Catherine H Choi; Brian P Schoenfeld; Aaron J Bell; Paul Hinchey; Maria Kollaros; Michael J Gertner; Newton H Woo; Michael R Tranfaglia; Mark F Bear; R Suzanne Zukin; Thomas V McDonald; Thomas A Jongens; Sean M J McBride
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

7.  The RNA binding protein CPEB regulates dendrite morphogenesis and neuronal circuit assembly in vivo.

Authors:  Jennifer E Bestman; Hollis T Cline
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-12       Impact factor: 11.205

Review 8.  Emotional modulation of the synapse.

Authors:  Jayme R McReynolds; Christa K McIntyre
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

Review 9.  Gephyrin: a master regulator of neuronal function?

Authors:  Shiva K Tyagarajan; Jean-Marc Fritschy
Journal:  Nat Rev Neurosci       Date:  2014-03       Impact factor: 34.870

10.  Importin-mediated retrograde transport of CREB2 from distal processes to the nucleus in neurons.

Authors:  Kwok-On Lai; Yali Zhao; Toh Hean Ch'ng; Kelsey C Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.